PDS Biotechnology Corp (PDSB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.70
• Market Cap: $38.80M
• EPS: $-0.81
• 52-Week High: $1.92
• 52-Week Low: $0.60

Market Sentiment

PDS Biotechnology Corp currently has a Bullish sentiment score of 0.36.

About PDS Biotechnology Corp

PDS Biotechnology Corporation (PDSB), headquartered in Florham Park, New Jersey, is a clinical-stage biopharmaceutical company pioneering innovative cancer immunotherapies through its proprietary Versamune® platform. The company is focused on developing multifunctional therapies that significantly enhance the immune response against cancer, with its lead candidate, PDS0101, undergoing clinical trials for HPV-related cancers. PDSB's commitment to efficacy and safety addresses critical unmet me...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PDS Biotechnology Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PDSB pay dividends?

PDS Biotechnology Corp (PDSB) does not currently pay a regular dividend.

What is PDSB's market cap?

PDS Biotechnology Corp (PDSB) has a market capitalization of $38.80M with a current stock price of $0.70.